MedTrace Logo

Testing a Spanish Version of a Patient Toxicity Questionnaire

NCT01517152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2019-12-16

No results posted yet for this study

Summary

Background:

* The Common Terminology Criteria for Adverse Events (CTCAE) is a list of toxicities and side effects that may occur when people are having cancer treatment. Doctors and nurses use this list to describe the side effects patients experience from cancer treatment. We have developed a questionnaire to ask people having cancer treatment directly about common symptoms and side effects and to supply this information to their doctors and nurses. This questionnaire is known as PRO-CTCAE and is completed by a patient.
* PRO-CTCAE was originally developed in English. Researchers want to develop a Spanish version of the patient questionnaire. To test whether the questions are well understood and whether it is easy to complete the questionnaire, the researchers will interview individuals whose primary language is Spanish and who are being treated for different types of cancer.

Objectives:

\- To test a Spanish version of the PRO-CTCAE questionnaire.

Eligibility:

\- Latinos at least 18 years of age who are having or have recently finished cancer treatments and whose main language is Spanish

Design:

* Participants will complete a questionnaire in Spanish with selected questions from the translated PRO-CTCAE. They will discuss their answers and any difficulties they might have had in understanding or answer the questions with an interviewer, who will take notes and record comments and suggestions.
* Literacy is not required for this study. Participants may opt to have the questions read aloud to them by an interviewer.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Sandra A Mitchell, C.R.N.P. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-04
Completion
2018-10-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01517152 on ClinicalTrials.gov